Alessandra Curioni-Fontecedro

Alessandra Curioni-Fontecedro

UNVERIFIED PROFILE

Are you Alessandra Curioni-Fontecedro?   Register this Author

Register author
Alessandra Curioni-Fontecedro

Alessandra Curioni-Fontecedro

Publications by authors named "Alessandra Curioni-Fontecedro"

Are you Alessandra Curioni-Fontecedro?   Register this Author

23Publications

661Reads

15Profile Views

Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence.

Clin Lung Cancer 2019 Sep 5;20(5):391-396. Epub 2019 Jun 5.

Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304193014
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2019.05.013DOI Listing
September 2019

Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program.

J Thorac Oncol 2018 12 7;13(12):1897-1905. Epub 2018 Aug 7.

Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.07.093DOI Listing
December 2018

Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results.

Lung Cancer 2018 12 3;126:170-173. Epub 2018 Nov 3.

Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.11.001DOI Listing
December 2018

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.

Radiat Oncol 2018 May 31;13(1):102. Epub 2018 May 31.

Department of Hematology and Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-018-1049-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984389PMC
May 2018

A new era of oncology through artificial intelligence.

ESMO Open 2017 15;2(2):e000198. Epub 2017 May 15.

Hematology and Oncology, Division of Oncology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519782PMC
May 2017

Mutant HRAS as novel target for MEK and mTOR inhibitors.

Oncotarget 2015 Dec;6(39):42183-96

Division of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5619DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747218PMC
December 2015

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

J Thorac Oncol 2015 Oct;10(10):1451-7

*Tumorzentrum, Luzerner Kantonsspital, Luzern, Switzerland; †Hôpital Larrey, Centre Hospital-Universitaire, Université Paul Sabatier, Toulouse, France; ‡Institut Claudius Regaud IUCT-O, Toulouse, France; §Institut Gustave Roussy, Villejuif, France; ¶VU University Medical Center, Amsterdam, The Netherlands; ‖Center of Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany; #Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; **Onkologie/Hämatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland; ††Medizinische Klinik, St. Claraspital, Basel, Switzerland; ‡‡Service de pneumologie et oncologie thoracique, Hopital Universitaire, Caen, France; §§University Hospital Essen, Essen, Germany; ¶¶University Hospital Zurich, Zurich, Switzerland; ‖‖Clinique Teissier, Valenciennes, France; ##Centre Hospitalier Intercommunal de Creteil, Créteil, France; ***University Hospital Innsbruck, Innsbruck, Austria; †††University Hospital Basel, Basel, Switzerland; ‡‡‡Heidelberg University Medical Center, Mannheim, Germany; §§§Hopital du Haut Lévèque, Pessac, France; ¶¶¶Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and ‖‖‖Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000625DOI Listing
October 2015

Chromosomal aberrations of cancer-testis antigens in myeloma patients.

Hematol Oncol 2015 Sep 13;33(3):159-63. Epub 2014 May 13.

Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2143DOI Listing
September 2015

[Diagnostic assessment of a pulmonary coin lesions with the example of a young patient].

Praxis (Bern 1994) 2012 Feb;101(5):289-97

Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a000846DOI Listing
February 2012

Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro.

Virol J 2010 Jul 29;7:175. Epub 2010 Jul 29.

Faculty of Mathematics and Natural Sciences, Institute of Molecular Life Sciences, University of Zürich, and Department of Dermatology, University Hospital of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-422X-7-175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920257PMC
July 2010